Hjem › Follikulært lymfom
Follikulært lymfom kliniske forsøg rekrutterer i USA
107 studier for Follikulært lymfom rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- New York City, NY24 studier
- Milwaukee, WI19 studier
- Houston, TX18 studier
- Nashville, TN18 studier
- Boston, MA17 studier
- Baldwin Park, CA16 studier
- Seattle, WA15 studier
- Durham, NC15 studier
- Columbus, OH13 studier
- Salt Lake City, UT13 studier
- Philadelphia, PA12 studier
- Chicago, IL12 studier
- San Antonio, TX12 studier
- Dallas, TX11 studier
- Los Angeles, CA11 studier
- Denver, CO11 studier
- Edison, NJ11 studier
- Atlanta, GA11 studier
- Washington, DC11 studier
- Rochester, MN10 studier
- Jacksonville, FL10 studier
- Portland, OR9 studier
- Cincinnati, OH9 studier
- Cleveland, OH9 studier
- New Haven, CT9 studier
- Pittsburgh, PA8 studier
- San Francisco, CA8 studier
- Miami, FL8 studier
- San Diego, CA8 studier
- Tampa, FL7 studier
- Charlotte, NC7 studier
- Clifton, NJ7 studier
- St. Louis, MO7 studier
- Mountain View, CA7 studier
- Queens, NY7 studier
- Cedar Rapids, IA7 studier
- Austin, TX6 studier
- Greenburgh, NY6 studier
- Winston-Salem, NC6 studier
- Buffalo, NY5 studier
Efter delstat
- Alabama5 studier
- Arizona11 studier
- Arkansas3 studier
- Californien36 studier
- Colorado14 studier
- Connecticut10 studier
- Delaware4 studier
- District of Columbia4 studier
- Florida25 studier
- Georgia15 studier
- Illinois14 studier
- Indiana7 studier
- Iowa9 studier
- Kansas7 studier
- Kentucky10 studier
- Louisiana8 studier
- Maryland9 studier
- Massachusetts20 studier
- Michigan12 studier
- Minnesota18 studier
- Mississippi4 studier
- Missouri9 studier
- Nebraska4 studier
- New Jersey15 studier
- New Mexico3 studier
- New York30 studier
- North Carolina23 studier
- Ohio23 studier
- Oklahoma4 studier
- Oregon11 studier
- Pennsylvania17 studier
- Rhode Island4 studier
- South Carolina6 studier
- Tennessee19 studier
- Texas35 studier
- Utah13 studier
- Virginia9 studier
- Washington19 studier
- Wisconsin21 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT03460977Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07215910Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruttererObservationsstudie
Alder 0 til 38 · Alle køn · Opdateret 1. okt. 2026 · NCT061318015HTP Regulation Of Asthma In Children
RekruttererFase 2
Alder 8 til 18 · Alle køn · Opdateret 1. okt. 2026 · NCT04160910Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07631598A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06542250A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT05006716Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06350318A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07634471A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07519772Epco, Zanu, Ritux for R/R FL or MZL
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06563596Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT06784167A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07226843Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06453044A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07101328A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT05765812A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
RekruttererFase 3
Alder 18 til 130 · Alle køn · Opdateret 21. sep. 2026 · NCT06549595huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07343934NEO100 and High-Grade Meningioma
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT05023018Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06526793Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
RekruttererFase 3
Alder 12 til 100 · Alle køn · Opdateret 11. sep. 2026 · NCT06784752A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06091254Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07225439A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT06043323A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
RekruttererObservationsstudie
Alder 0 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT07154823Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.